Clinical Trial Update: DAA-based Therapy for Recently Acquired Hepatitis C II (DAA = Directly Acting Antiviral) [Phase 4]

View source ↗

Summary

Phase 4 trial update on direct-acting antiviral therapy for recently acquired hepatitis C; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Snippet

Sponsor: Kirby Institute | Conditions: Hepatitis C | Phase 4 | Status: COMPLETED